17β-hydroxysteroid dehydrogenase type 3 deficiency: female sex assignment and follow-up
- 15 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Endocrinological Investigation
- Vol. 43 (12), 1711-1716
- https://doi.org/10.1007/s40618-020-01248-y
Abstract
Background Deficiency of 17β-hydroxysteroid dehydrogenase type 3 (17β-HSD3) is a rare autosomal recessive 46,XY disorder of sex development (DSD). It is due to pathogenetic variants in the HSD17B3 gene. Mutated genes encode an abnormal enzyme with absent or reduced ability to convert Δ4-androstenedione (Δ4-A) to testosterone (T) in the fetal testis. Affected individuals are usually raised as females and diagnosis is made at puberty, when they show virilization. Methods A girl with a presumptive diagnosis of complete androgen insensitivity syndrome underwent endocrine and genetic assessment. Long-term follow-up was reported. Results The diagnosis of 17β-HSD3 deficiency was made (stimulated T/Δ4-A ratio: 0.15; HSD17B3 gene analysis: c.277+4A>T in intron 3/c.640_645del (p.Glu214_Glu215del) in exon 9. After extensive information, parents decided to maintain female sex. Gonadal removal was performed and histological evaluation demonstrated deep fibrosis of testicular tissue. Follow-up till 8.5 years of age showed somatic and neuro-psychological development fitting with the female sex. Conclusions Management of a child with the rare 17β-HSD3 deficiency remains challenging. Any decision must be carefully evaluated with parents. Long-term follow-up must be warranted by a multidisciplinary DSD team to evaluate the adequacy of the choices made on quality of life in later life.Keywords
This publication has 28 references indexed in Scilit:
- Complexities of gender assignment in 17β-hydroxysteroid dehydrogenase type 3 deficiency: is there a role for early orchiectomy?International Journal of Pediatric Endocrinology, 2013
- Clinical and molecular spectrum of patients with 17β-hydroxysteroid dehydrogenase type 3 (17-β-HSD3) deficiencyArchives of Endocrinology and Metabolism, 2012
- The Clinical and Molecular Heterogeneity of 17βHSD-3 Enzyme DeficiencyHormone Research in Paediatrics, 2010
- 17β-Hydroxysteroid dehydrogenase-3 deficiency: From pregnancy to adolescenceJournal of Endocrinological Investigation, 2009
- Clinical, endocrine, and molecular findings in 17β -hydroxysteroid dehydrogenase type 3 deficiencyJournal of Endocrinological Investigation, 2008
- Phenotypic variability in 17β‐hydroxysteroid dehydrogenase‐3 deficiency and diagnostic pitfallsClinical Endocrinology, 2007
- Consensus statement on management of intersex disordersArchives of Disease in Childhood, 2005
- 17β-Hydroxysteroid Dehydrogenase-3 Deficiency: Diagnosis, Phenotypic Variability, Population Genetics, and Worldwide Distribution of Ancient and de Novo Mutations1Journal of Clinical Endocrinology & Metabolism, 1999
- Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency.Journal of Clinical Endocrinology & Metabolism, 1996
- Male pseudohermaphroditism caused by mutations of testicular 17β–hydroxysteroid dehydrogenase 3Nature Genetics, 1994